Autocrine IL-10 functions as a rheostat for M1 macrophage glycolytic commitment by tuning nitric oxide production

Redox Biology

Volumn 10, Issue , 2016, Pages 12-23

  Baseler, Walter A ^a   Davies, Luke C ^a,b   Quigley, Laura ^a   Ridnour, Lisa A ^a   Weiss, Jonathan M ^a   Hussain, S Perwez ^c   Wink, David A ^a   McVicar, Daniel W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE; GLUCOSE; IL10 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

AEROBIC GLYCOLYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVELOPMENTAL STAGE; HUMAN; HUMAN CELL; MACROPHAGE; METABOLITE; METABOLOMICS; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GLYCOLYSIS; MACROPHAGE ACTIVATION; METABOLISM; MITOCHONDRION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; GLUCOSE; GLYCOLYSIS; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MITOCHONDRIA; NITRIC OXIDE; OXIDATIVE PHOSPHORYLATION; TOR SERINE-THREONINE KINASES;

EID: 84988649474     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2016.09.005     Document Type: Article

References (29)

1. [1] Soehnlein, O., Lindbom, L., Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10 (2010), 427–439.
2. [2] Davies, L.C., Taylor, P.R., Tissue-resident macrophages: then and now. Immunology 144 (2015), 541–548.
3. [3] Ganeshan, K., Chawla, A., Metabolic regulation of immune responses. Annu. Rev. Immunol. 32 (2014), 609–634.
4. [4] Tannahill, G.M., Curtis, A.M., Adamik, J., Palsson-McDermott, E.M., McGettrick, A.F., Goel, G., Frezza, C., Bernard, N.J., Kelly, B., Foley, N.H., Zheng, L., Gardet, A., Tong, Z., Jany, S.S., Corr, S.C., Haneklaus, M., Caffrey, B.E., Pierce, K., Walmsley, S., Beasley, F.C., Cummins, E., Nizet, V., Whyte, M., Taylor, C.T., Lin, H., Masters, S.L., Gottlieb, E., Kelly, V.P., Clish, C., Auron, P.E., Xavier, R.J., O'Neill, L.A., Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496 (2013), 238–242.
5. [5] Everts, B., Amiel, E., Huang, S.C., Smith, A.M., Chang, C.H., Lam, W.Y., Redmann, V., Freitas, T.C., Blagih, J., van der Windt, G.J., Artyomov, M.N., Jones, R.G., Pearce, E.L., Pearce, E.J., TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation. Nat. Immunol. 15 (2014), 323–332.
6. [6] Rodriguez-Prados, J.C., Traves, P.G., Cuenca, J., Rico, D., Aragones, J., Martin-Sanz, P., Cascante, M., Bosca, L., Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185 (2010), 605–614.
7. [7] Vats, D., Mukundan, L., Odegaard, J.I., Zhang, L., Smith, K.L., Morel, C.R., Wagner, R.A., Greaves, D.R., Murray, P.J., Chawla, A., Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 4 (2006), 13–24.
8. [8] Huang, S.C., Everts, B., Ivanova, Y., O'Sullivan, D., Nascimento, M., Smith, A.M., Beatty, W., Love-Gregory, L., Lam, W.Y., O'Neill, C.M., Yan, C., Du, H., Abumrad, N.A., Urban, J.F. Jr., Artyomov, M.N., Pearce, E.L., Pearce, E.J., Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 15 (2014), 846–855.
9. [9] Yang, L., Xie, M., Yang, M., Yu, Y., Zhu, S., Hou, W., Kang, R., Lotze, M.T., Billiar, T.R., Wang, H., Cao, L., Tang, D., PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun., 5, 2014, 4436.
10. [10] Kim, J.W., Tchernyshyov, I., Semenza, G.L., Dang, C.V., HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3 (2006), 177–185.
11. [11] Everts, B., Amiel, E., van der Windt, G.J., Freitas, T.C., Chott, R., Yarasheski, K.E., Pearce, E.L., Pearce, E.J., Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 120 (2012), 1422–1431.
12. [12] Krawczyk, C.M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R.J., Cross, J.R., Jung, E., Thompson, C.B., Jones, R.G., Pearce, E.J., Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115 (2010), 4742–4749.
13. [13] Turnbull, I.R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., Colonna, M., Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177 (2006), 3520–3524.
14. [14] Sen, S.K., Boelte, K.C., Barb, J.J., Joehanes, R., Zhao, X., Cheng, Q., Adams, L., Teer, J.K., Accame, D.S., Chowdhury, S., Singh, L.N., Kavousi, M., Peyser, P.A., Quigley, L., Priel, D.L., Lau, K., Kuhns, D.B., Yoshimura, T., Johnson, A.D., Hwang, S.J., Chen, M.Y., Arai, A.E., Green, E.D., Mullikin, J.C., Kolodgie, F.D., O'Donnell, C.J., Virmani, R., Munson, P.J., McVicar, D.W., Biesecker, L.G., Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcification. Am. J. Hum. Genet. 95 (2014), 66–76.
15. [15] Whittaker, G.C., Orr, S.J., Quigley, L., Hughes, L., Francischetti, I.M., Zhang, W., McVicar, D.W., The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells. J. Biol. Chem. 285 (2010), 2976–2985.
16. [16] Hardie, D.G., Ross, F.A., Hawley, S.A., AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13 (2012), 251–262.
17. [17] Strelko, C.L., Lu, W., Dufort, F.J., Seyfried, T.N., Chiles, T.C., Rabinowitz, J.D., Roberts, M.F., Itaconic acid is a mammalian metabolite induced during macrophage activation. J. Am. Chem. Soc. 133 (2011), 16386–16389.
18. [18] MacIver, N.J., Michalek, R.D., Rathmell, J.C., Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31 (2013), 259–283.
19. [19] Lucas, M., Zhang, X., Prasanna, V., Mosser, D.M., ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J. Immunol. 175 (2005), 469–477.
20. [20] Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T., Koyasu, S., PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3 (2002), 875–881.
21. [21] Saraiva, M., O'Garra, A., The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10 (2010), 170–181.
22. [22] Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K.M., Kolbe, T., Stulnig, T.M., Horl, W.H., Hengstschlager, M., Muller, M., Saemann, M.D., The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29 (2008), 565–577.
23. [23] Cleeter, M.W., Cooper, J.M., Darley-Usmar, V.M., Moncada, S., Schapira, A.H., Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 345 (1994), 50–54.
24. [24] Clementi, E., Brown, G.C., Feelisch, M., Moncada, S., Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl. Acad. Sci. USA 95 (1998), 7631–7636.
25. [25] Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., Brune, B., Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol. Biol. Cell 14 (2003), 3470–3481.
26. [26] Jha, A.K., Huang, S.C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K.M., Ashall, J., Everts, B., Pearce, E.J., Driggers, E.M., Artyomov, M.N., Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42 (2015), 419–430.
27. [27] Cunha, F.Q., Moncada, S., Liew, F.Y., Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem. Biophys. Res. Commun. 182 (1992), 1155–1159.
28. [28] Huang, W.C., Lin, Y.S., Wang, C.Y., Tsai, C.C., Tseng, H.C., Chen, C.L., Lu, P.J., Chen, P.S., Qian, L., Hong, J.S., Lin, C.F., Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 128 (2009), e275–e286.
29. [29] Huang, C.J., Stevens, B.R., Nielsen, R.B., Slovin, P.N., Fang, X., Nelson, D.R., Skimming, J.W., Interleukin-10 inhibition of nitric oxide biosynthesis involves suppression of CAT-2 transcription. Nitric Oxide 6 (2002), 79–84.